HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
Leo, Angelo Di, Dr, Desmedt, Christine, PhD, Bartlett, John M S, Prof, Piette, Fanny, PhD, Ejlertsen, Bent, MD, Pritchard, Kathleen I, Prof, Larsimont, Denis, MD, Poole, Christopher, Prof, Isola, Jorma, Prof, Earl, Helena, Prof, Mouridsen, Henning, MD, O'Malley, Frances P, MD, Cardoso, Fatima, MD, Tanner, Minna, MD, Munro, Alison, PhD, Twelves, Chris J, Prof, Sotiriou, Christos, MD, Shepherd, Lois, MD, Cameron, David, Prof, Piccart, Martine J, Prof, Buyse, Marc, PhD
Published in The lancet oncology (01.11.2011)
Published in The lancet oncology (01.11.2011)
Get full text
Journal Article
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
Bartlett, John MS, Prof, Munro, Alison F, MSc, Dunn, Janet A, PhD, McConkey, Christopher, MSc, Jordan, Sarah, MSc, Twelves, Chris J, Prof, Cameron, David A, Prof, Thomas, Jeremy, MBBS, Campbell, Fiona M, MSc, Rea, Daniel W, PhD, Provenzano, Elena, MBBS, Caldas, Carlos, Prof, Pharoah, Paul, BMBCh, Hiller, Louise, PhD, Earl, Helena, MBBS, Poole, Christopher J, Prof
Published in The lancet oncology (01.03.2010)
Published in The lancet oncology (01.03.2010)
Get full text
Journal Article
Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial
BARTLETT, John M. S, MUNRO, Alison, CAMERON, David A, THOMAS, Jeremy, PRESCOTT, Robin, TWELVES, Chris J
Published in Journal of clinical oncology (01.11.2008)
Published in Journal of clinical oncology (01.11.2008)
Get full text
Journal Article
In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
Spears, Melanie, Taylor, Karen J., Munro, Alison F., Cunningham, Carrie A., Mallon, Elizabeth A., Twelves, Chris J., Cameron, David A., Thomas, Jeremy, Bartlett, John M. S.
Published in Breast cancer research and treatment (01.04.2012)
Published in Breast cancer research and treatment (01.04.2012)
Get full text
Journal Article
Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study
ALBERTELLA, Mark R, LOADMAN, Paul M, HARRIS, Peter A, WONG, Alvin, LALANI, Alshad S, TWELVES, Chris J, JONES, Philip H, PHILLIPS, Roger M, RAMPLING, Roy, BURNET, Neil, ALCOCK, Chris, ANTHONEY, Alan, VJATERS, Egils, DUNK, Chris R
Published in Clinical cancer research (15.02.2008)
Published in Clinical cancer research (15.02.2008)
Get full text
Journal Article
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer
Walls, Gerard M., Oughton, Jamie B., Chalmers, Anthony J., Brown, Sarah, Collinson, Fiona, Forster, Martin D., Franks, Kevin N., Gilbert, Alexandra, Hanna, Gerard G., Hannaway, Nicola, Harrow, Stephen, Haswell, Tom, Hiley, Crispin T., Hinsley, Samantha, Krebs, Matthew, Murden, Geraldine, Phillip, Rachel, Ryan, Anderson J., Salem, Ahmed, Sebag-Montefoire, David, Shaw, Paul, Twelves, Chris J., Walker, Katrina, Young, Robin J., Faivre-Finn, Corinne, Greystoke, Alastair
Published in Clinical and translational radiation oncology (01.11.2020)
Published in Clinical and translational radiation oncology (01.11.2020)
Get full text
Journal Article
Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Samson, Adel, West, Emma J, Carmichael, Jonathan, Scott, Karen J, Turnbull, Samantha, Kuszlewicz, Bethany, Dave, Rajiv V, Peckham-Cooper, Adam, Tidswell, Emma, Kingston, Jennifer, Johnpulle, Michelle, da Silva, Barbara, Jennings, Victoria A, Bendjama, Kaidre, Stojkowitz, Nicolas, Lusky, Monika, Prasad, K R, Toogood, Giles J, Auer, Rebecca, Bell, John, Twelves, Chris J, Harrington, Kevin J, Vile, Richard G, Pandha, Hardev, Errington-Mais, Fiona, Ralph, Christy, Newton, Darren J, Anthoney, Alan, Melcher, Alan A, Collinson, Fiona
Published in Cancer immunology research (03.06.2022)
Published in Cancer immunology research (03.06.2022)
Get more information
Journal Article
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study
Twelves, Chris J, Butts, Charles A, Cassidy, Jim, Conroy, Thierry, Braud, Fillippo de, Diaz-Rubio, Eduardo, Tabernero, Josep M, Schoffski, Patrick, Figer, Arie, Brunet, Rene, Grossmann, Johannes, Sobrero, Alberto F, Van Cutsem, Eric J
Published in Clinical colorectal cancer (01.07.2005)
Published in Clinical colorectal cancer (01.07.2005)
Get full text
Journal Article
Abstract 5507: The development and evaluation of a model for assessing convective fluid flow through multicell layers in vitro
Phillips, Roger M., Loadman, Paul M., Periasamy, Nagarajan, Twelves, Chris J., Jones, Pam F., Evans, Chris J., Sleeman, Brian D., Smye, Stephen W.
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Capecitabine/Oxaliplatin, a Safe and Active First-Line Regimen for Older Patients Metastatic Colorectal Cancer: Post Hoc Analysis of a Large Phase II Study
Twelves, Chris J., Butts, Charles A., Cassidy, Jim, Conroy, Thierry, de Braud, Filippo, Díaz-Rubio, Eduardo, Tabernero, Josep M., Schöffski, Patrick, Figer, Arie, Brunet, René, Grossmann, Johannes, Sobrero, Alberto F., Van Cutsem, Eric J.
Published in Clinical colorectal cancer (01.07.2005)
Published in Clinical colorectal cancer (01.07.2005)
Get full text
Journal Article